1. 148 Antimalarial agents and other immunosuppressants influence BAFF levels in opposite directions in patients with systemic lupus erythematosus. (April 2019) Authors: Hernandez-Breijo, Borja; Gomez, Alvaro; Johansson, Petter; Soukka, Sofia; Parodis, Ioannis Journal: Lupus science & medicine Issue: Volume 6(2019)supplement 1 Page Start: A107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 150 Antimalarial agents improve physical functioning in patients with systemic lupus erythematosus. (April 2019) Authors: Parodis, Ioannis; Soukka, Sofia; Gomez, Alvaro; Johansson, Petter; Emamikia, Sharzad; Enman, Yvonne; Chatzidionysiou, Katerina Journal: Lupus science & medicine Issue: Volume 6(2019)supplement 1 Page Start: A108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0175 PREDICTORS OF LOW DISEASE ACTIVITY AND CLINICAL REMISSION FOLLOWING BELIMUMAB TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS. (June 2019) Authors: Parodis, Ioannis; Johansson, Petter; Gomez, Alvaro; Soukka, Sofia; Emamikia, Sharzad; Chatzidionysiou, Katerina Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 761 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0198 ANTIMALARIAL AGENTS DIMINISH WHILE METHOTREXATE, AZATHIOPRINE AND MYCOPHENOLIC ACID INCREASE BAFF LEVELS IN SYSTEMIC LUPUS ERYTHEMATOSUS. (June 2019) Authors: Hernández-Breijo, Borja; Gomez, Alvaro; Soukka, Sofia; Johansson, Petter; Parodis, Ioannis Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0205 ANTIMALARIAL AGENTS IMPROVE PHYSICAL FUNCTIONING IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. (June 2019) Authors: Parodis, Ioannis; Soukka, Sofia; Gomez, Alvaro; Enman, Yvonne; Johansson, Petter; Emamikia, Sharzad; Chatzidionysiou, Katerina Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 781 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impact of overweight and obesity on patient-reported health-related quality of life in systemic lupus erythematosus. (11th September 2020) Authors: Gomez, Alvaro; Hani Butrus, Fawz; Johansson, Petter; Åkerström, Emil; Soukka, Sofia; Emamikia, Sharzad; Enman, Yvonne; Pettersson, Susanne; Parodis, Ioannis Journal: Rheumatology Issue: Volume 60:Number 3(2021) Page Start: 1260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P170 Antimalarial agent use is associated with favourable physical functioning in patients with systemic lupus erythematosus. (23rd March 2020) Authors: Parodis, Ioannis; Soukka, Sofia; Gomez, Alvaro; Enman, Yvonne; Johansson, Petter; Emamikia, Sharzad; Chatzidionysiou, Katerina Journal: Lupus science & medicine Issue: Volume 7(2020)Supplement 1 Page Start: A113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Predictors of low disease activity and clinical remission following belimumab treatment in systemic lupus erythematosus. (3rd June 2019) Authors: Parodis, Ioannis; Johansson, Petter; Gomez, Alvaro; Soukka, Sofia; Emamikia, Sharzad; Chatzidionysiou, Katerina Journal: Rheumatology Issue: Volume 58:Number 12(2019) Page Start: 2170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗